Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 8/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.37 |
| ▸ | GABRE | P78334 | 1/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.37 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.37 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29849780 | 0.84 | GABRP (0.41) | PTGER4CYP1A2GABRPGABRDGABRA1 | |
| SCHEMBL29366895 | 0.77 | ALDH1A1 (0.50) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL51657 | 0.77 | ALDH1A1 (0.50) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL755011 | 0.75 | ALDH1A1 (0.48) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL3215387 | 0.72 | ALDH1A1 (0.39) | MEN1KMT2AKDM4EALDH1A1MAPK1 | |
| SCHEMBL2257033 | 0.72 | PTGER4 (0.47) | PTGER4CYP1A2CYP2D6KDM4EALDH1A1 | |
| SCHEMBL23271679 | 0.71 | ALDH1A1 (0.44) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL30003317 | 0.71 | ALDH1A1 (0.44) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL30660757 | 0.70 | ALDH1A1 (0.42) | PTGER4CYP1A2CYP2D6GABRPGABRD | |
| SCHEMBL23271850 | 0.70 | ALDH1A1 (0.68) | PTGER4CYP1A2CYP2D6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7322927-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE INCORPORATED | 2006-10-12 | — | — | US | disclosed |
| US-7083984-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2006-08-01 | — | — | US | disclosed |
| US-6964844-B1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-20020061602-A1 | Hybrid phthalocyanine derivatives and their uses | GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT | 2002-05-23 | — | — | US | disclosed |
| EP-0670041-B1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC (US) | 2002-01-30 | — | — | EP | disclosed |
| EP-0820489-B1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INC (US) | 2001-07-11 | — | — | EP | disclosed |
| US-6251687-B1 | PARTICLE CONTAINING ENERGY DONOR AND ENERGY ACCEPTOR | BIOSITE DIAGNOSTICS, INC. | 2001-06-26 | — | — | US | disclosed |
| US-6238931-B1 | PARTICLES WITH ENERGY DONORS AND ACCEPTORS AS WELL AS PROTEINS, POLYPEPTIDES, NUCLEIC ACIDS, OR LIGAND ANALOGUES BOUND TO SURFACE; WITH REDUCED QUENCHING AND IMPROVED FLUORESCENCE INTENSITIES; IMMUNOASSAYS | BIOSITE DIAGNOSTICS, INC. | 2001-05-29 | — | — | US | disclosed |
| EP-0670041-A4 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS. | BIOSITE DIAGNOSTICS INC (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996029367-A1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1996-09-26 | — | — | WO | disclosed |
| EP-0670041-A1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC. (US) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995008772-A1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1995-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | UACA, PHAX, PTBP1 | PTGER4 4324/4885CYP1A2 4811/4885CYP2D6 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.